UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14C INFORMATION
(Rule 14c-101)
Information Statement Pursuant to Section 14(c)
of the Securities Exchange Act of 1934
Check the appropriate box:
[X] | Preliminary Information Statement |
| |
[ ] | Confidential, for Use of the Commission Only (as permitted by Rule 14A-6(e)(2)) |
| |
[ ] | Definitive Information Statement |
HARTFORD GREAT HEALTH CORP.
(Name of Registrant as Specified In Its Charter)
Payment of Filing Fee (Check the appropriate box):
[X] | No fee required. |
| |
[ ] | Fee computed on table below per Exchange Act Rules 14c-5(g) and 0-11. |
| (1) | Title of each class of securities to which transaction applies:___________ |
| | |
| (2) | Aggregate number of securities to which transaction applies:___________ |
| | |
| (3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):____________ |
| | |
| (4) | Proposed maximum aggregate value of transaction:____________ |
| | |
| (5) | Total fee paid:____________ |
[ ] | Fee paid previously with preliminary materials. |
[ ] Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
(1) | Amount Previously Paid:___________ |
| |
(2) | Form, Schedule or Registration Statement No.:___________ |
| |
(3) | Filing Party:___________ |
| |
(4) | Date Filed:___________ |
HARTFORD GREAT HEALTH CORP.
8832 Glendon Way
Rosemead, Nevada 91770
INFORMATION STATEMENT
PURSUANT TO SECTION 14
OF THE SECURITIES EXCHANGE ACT OF 1934
AND REGULATION 14C AND SCHEDULE 14C THEREUNDER
WE ARE NOT ASKING YOU FOR A PROXY
AND YOU ARE NOT REQUESTED TO SEND US A PROXY
This information statement has been mailed on or about May __, 2019 to the shareholders of record on April 30, 2019 (the “Record Date”) of Hartford Great Health Corp., a Nevada corporation (the “Company”), in connection with certain actions to be taken by the written consent by the holders of a majority of the voting power of the outstanding capital stock of the Company, dated as of April 30, 2019. The actions to be taken pursuant to the written consent may be taken on or about June __, 2019, 20 days after the mailing of this information statement.
THIS IS NOT A NOTICE OF A SPECIAL MEETING OF SHAREHOLDERS AND NO SHAREHOLDER MEETING WILL BE HELD TO CONSIDER ANY MATTER WHICH WILL BE DESCRIBED HEREIN.
WE ARE NOT ASKING YOU FOR A PROXY
AND YOU ARE NOT REQUESTED TO SEND US A PROXY
By Order of the Board of Directors,
/s/ Lianyue Song
President
NOTICE OF ACTION TO BE TAKEN PURSUANT THE WRITTEN CONSENT OF THE SHAREHOLDER HOLDING A MAJORITY OF THE VOTING POWER OF THE OUTSTANDING SHARES OF STOCK OF THE COMPANY IN LIEU OF A SPECIAL MEETING OF THE SHAREHOLDERS.
To the Company’s Shareholders:
NOTICE IS HEREBY GIVEN that the following action has been approved pursuant to the written consent of the holders of a majority of the voting power of the outstanding capital stock of the Company dated April 30, 2019, in lieu of a special meeting of the shareholders.
To amend the Company’s certificate of incorporation to (1) increase (the “Increase”) the authorized shares of common stock of the Company from 100,000,000 shares to 300,000,000 shares of $0.001 par value (the “Amendment”).
OUTSTANDING SHARES AND VOTING RIGHTS
As of the record date of April 30, 2019 (the “Record Date”), the Company’s authorized capitalization consisted of 100,000,000 shares of Common Stock, of which 99,108,000 shares were issued and outstanding and 5,000,000 of Preferred Stock of which no shares were issued and outstanding. Each share of Common Stock entitles its holder to one vote on each matter submitted to the shareholders. However, because shareholders holding a majority of the voting rights of all outstanding shares of common stock as of April 30, 2019 have voted in favor of the foregoing action by resolution dated April 30, 2019, no other shareholder consents will be solicited in connection with this Information Statement.
Shareholders of record on the Record Date will be entitled to receive this notice and Information Statement.
Pursuant to Rule 14c-2 under the Securities Exchange Act of 1934, as amended, the actions described herein will not be implemented until a date at least 20 days after the date on which this Information Statement has been mailed to the shareholders. The Company anticipates that the Amendment will be effectuated on or about June __, 2019.
What action was taken by written consent?
We obtained stockholder consent for the approval of an amendment to our certificate of incorporation to increase our authorized shares of common stock, $0.001 par value (the “Common Stock”) from 100,000,000 to 300,000,000.
How many shares of voting stock were outstanding on the Record Date?
On the Record Date, the date we received the consent of the holders of a majority of the voting power of our stockholders, there were 99,108,000 shares of Common Stock outstanding.
What vote was obtained to approve the amendment to the articles of incorporation described in this information statement?
Our board of directors approved the Amendment at special meetings of the board of directors on April 30, 2019. Stockholder approval of the Amendment also was required. The affirmative vote of the holders of a majority of the voting power entitled to vote on the Amendment constituted the act of the stockholders with regard to the Amendment. The voting power entitled to vote on the Amendment approved the Amendment by approximately 52.9% and of the vote of the holders of the common stock with each share of common stock having one vote. Only stockholders of record at the close of business on the record date are entitled to notice of and to approve the Amendment.
AMENDMENT TO THE CERTIFICATE OF INCORPORATION
TO INCREASE AUTHORIZED SHARES OF COMMON STOCK FROM 100,000,000 TO 300,000,000
Our board of directors and the holders of a majority of the voting power of our stockholders have approved the amendment to our articles of incorporation (the “Amendment”) increasing our authorized shares of Common Stock from 100,000,000 shares to 300,000,000 shares. The increase in our authorized shares of Common Stock will become effective upon the filing of the Amendment with the Secretary of State of the State of Nevada. We will file the Amendment approximately (but not less than) 20 days after the definitive information statement is mailed to stockholders.
The form of Certificate of Amendment to be filed with the Secretary of State of the State of Nevada is set forth as Appendix A to this information statement.
Outstanding Shares and Purpose of the Amendment
Our articles of incorporation currently authorize us to issue a maximum of 100,000,000 shares of Common Stock, $0.001 par value per share and 5,000,000 shares of Preferred Stock. As of the Record Date, we had 99,108,000 shares of Common Stock issued and outstanding and no shares of Preferred Stock issued and outstanding.
The board of directors believes that the increase in our authorized Common Stock will provide us with greater flexibility with respect to our capital structure for business purposes including additional equity financings and stock based acquisitions.
Effects of the Increase in Authorized Common Stock
The additional shares of Common Stock will have the same rights as the presently authorized shares, including the right to cast one vote per share of Common Stock. Although the authorization of additional shares will not, in itself, have any effect on the rights of any holder of our Common Stock, the future issuance of additional shares of Common Stock (other than by way of a stock split or dividend) would have the effect of diluting the voting rights and could have the effect of diluting earnings per share and book value per share of existing stockholders.
At present, the board of directors has no plans to issue the additional shares of Common Stock authorized by the Amendment. However, it is possible that some of these additional shares could be used in the future for various other purposes without further stockholder approval, except as such approval may be required in particular cases by our charter documents, applicable law or the rules of any stock exchange or other quotation system on which our securities may then be listed. These purposes may include: raising capital, settlement of debt, providing equity incentives to employees, officers or directors, establishing strategic relationships with other companies, and expanding our business or product lines through the acquisition of other businesses or products.
We could also use the additional shares of Common Stock that will become available pursuant to the Amendment to oppose a hostile takeover attempt or to delay or prevent changes in control or management of our company. Although the board’s approval of the Amendment was not prompted by the threat of any hostile takeover attempt (nor is the board currently aware of any such attempts directed at us), nevertheless, stockholders should be aware that the Amendment could facilitate future efforts by us to deter or prevent changes in control of our company, including transactions in which our stockholders might otherwise receive a premium for their shares over then current market prices.
Interests of Certain Persons in the Action
Certain of the Company’s officers and directors have an interest in the Amendment as a result of their ownership of shares of our common stock, as set forth in the section entitled “Security Ownership of Certain Beneficial Owners and Management” below. However, we do not believe that our officers or directors have interests in the Amendment that are different from or greater than those of any other of our stockholders.
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The following table sets forth certain information regarding beneficial ownership of the Company’s Common Stock as of the Record Date by (i) each person who is known by us to beneficially own more than 5% of the Company’s Common Stock; (ii) each of the Company’s officers and directors; and (iii) all of the Company’s officers and directors as a group.
Beneficial ownership has been determined in accordance with the rules and regulations of the Securities and Exchange Commission (the “Commission”) and includes voting or investment power with respect to the shares. Unless otherwise indicated, the persons named in the table below have sole voting and investment power with respect to the number of shares indicated as beneficially owned by them.
Name and Address of Beneficial Owner | | Amount of Beneficial Ownership | | | Percent of Outstanding Stock (1) | |
| | | | | | |
Yuan Lu | | | 32,440,000 | | | | 32.7 | % |
| | | | | | | | |
Lianyue Song | | | 20,000,000 | | | | 20.2 | % |
| | | | | | | | |
Sheng-Yih Chang | | | 1,000,000 | | | | 1.0 | % |
| | | | | | | | |
Xin Dong | | | 2,400.000 | | | | 2.4 | % |
| | | | | | | | |
Xueying Song | | | 1,000,000 | | | | 1.0 | % |
| | | | | | | | |
All Executive Officers and | | | | | | | | |
Directors as a Group (5 Person) | | | 56,840,000 | | | | 57.3 | % |
DESCRIPTION OF SECURITIES
General
The following summary includes a description of material provisions of our capital stock.
Authorized and Outstanding Securities
We have the authority to issue up to 100,000,000 shares of Common Stock, $0.001 par value. As of April 30, 2019, there were 99,108,000 shares of Common Stock issued and outstanding.
Common Stock
The holders of our Common Stock are entitled to one vote per share on all matters requiring a vote of the stockholders, including the election of directors. Holders of Common Stock do not have cumulative voting rights. Holders of Common Stock are entitled to share ratably in dividends, if any, as may be declared from time to time by the Board in its discretion from funds legally available therefore, subject to preferences that may be applicable to preferred stock, if any, then outstanding. At present, we have no plans to issue dividends. See “Dividend Policy” for additional information. In the event of a liquidation, dissolution or winding up of the Company, the holders of Common Stock are entitled to share pro rata all assets remaining after payment in full of all liabilities, subject to prior distribution rights of preferred stock, if any, then outstanding. The Common Stock has no preemptive or conversion rights or other subscription rights. There are no redemption or sinking fund provisions applicable to the Common Stock. Our Common Stock is traded on the OTC market.
Preferred Stock
Preferred stock may be issued from time to time in one or more series, and our board of directors, without action by the holders of common stock, may fix or alter the voting rights, redemption provisions, dividend rights, dividend rates, claims to our assets superior to those of holders of our common stock, conversion rights and any other rights, preferences, privileges and restrictions of any wholly unissued series of preferred stock. The board of directors, without stockholder approval, can issue shares of preferred stock with rights that could adversely affect the rights of the holders of common stock. No shares of preferred stock presently are outstanding other than the shares of our Series A Convertible Preferred Stock, and we have no present plans to issue any additional preferred shares. The issuance of shares of preferred stock could adversely affect the voting power of the holders of common stock and could have the effect of making it more difficult for a third party to acquire, or could discourage or delay a third party from acquiring, a majority of our outstanding stock.
Dividend Policy
Dividends, if any, will be contingent upon our revenues and earnings, if any, capital requirements and financial conditions. The payment of dividends, if any, will be within the discretion of our Board. We intend to retain earnings, if any, for use in its business operations and accordingly, the Board does not anticipate declaring any dividends in the foreseeable future.
DISSENTER’S RIGHTS
Under the Nevada Statutes, holders of shares of Common Stock or Preferred Stock are not entitled to dissenters’ rights with respect to any aspect of the Amendment, and we will not independently provide holders with any such right.
FORWARD-LOOKING STATEMENTS AND INFORMATION
This Information Statement includes forward-looking statements. You can identify the Company’s forward-looking statements by the words “expects,” “projects,” “believes,” “anticipates,” “intends,” “plans,” “predicts,” “estimates” and similar expressions.
The forward-looking statements are based on management’s current expectations, estimates and projections about us. The Company cautions you that these statements are not guarantees of future performance and involve risks, uncertainties and assumptions that we cannot predict. In addition, the Company has based many of these forward-looking statements on assumptions about future events that may prove to be inaccurate. Accordingly, actual outcomes and results may differ materially from what the Company has expressed or forecast in the forward-looking statements.
You should rely only on the information the Company has provided in this Information Statement. The Company has not authorized any person to provide information other than that provided herein. The Company has not authorized anyone to provide you with different information. You should not assume that the information in this Information Statement is accurate as of any date other than the date on the front of the document.
ADDITIONAL INFORMATION
The Company will provide upon request and without charge to each shareholder receiving this Information Statement a copy of the Company’s Annual Report on Form 10-K filed on November 14, 2018, which includes audited financial statements for the years ended July 31, 2018, and December 31, 2017, and the quarterly report on Form 10-Q for the quarter ended January 31, 2019, including the financial statements and financial statement schedule information included therein, as filed with the Commission. Reports and other information filed by the Company can be inspected and copied at the public reference facilities maintained at the Commission at 100 F Street, N.E., Washington, DC 20549. Copies of such material can be obtained upon written request addressed to the Commission, Public Reference Section, 100 F Street, N.E., Washington, D.C. 20549, at prescribed rates. The Commission maintains a web site on the Internet (http://www.sec.gov) that contains reports, proxy and information statements and other information regarding issuers that file electronically with the Commission through the Electronic Data Gathering, Analysis and Retrieval System.
By order of the Board of Directors
May___, 2019
/s/Lianyue Song
Lianyue Song
President
Appendix A
CERTIFICATE OF AMENDMENT
TO THE
ARTICLES OF INCORPORATION
LIANYUE SONG certifies that:
1. He is the president of Hartford Great Health Corp., a Nevada corporation.
2. Article III of the Articles of Incorporation of this corporation is amended to read as follows:
”ARTICLE III
Capital Stock
1. Authorized Shares of Common Stock . The aggregate number of shares of stock which the corporation shall have authority to issue is 300,000,000 shares of $.001 par value Common Stock. The shares of this class of Common Stock shall have unlimited voting rights and shall constitute the sole voting group of the corporation, except to the extent any additional voting group or groups may hereafter be established in accordance with the Nevada Revised Statutes. The shares of this class shall also be entitled to receive the net assets of the corporation upon dissolution.
2. Voting Rights: Denial of Preemptive Rights . Each shareholder of record shall have one vote for each share of stock standing in his name on the books of the corporation and entitled to vote, except that in the election of directors each shareholder shall have as many votes for each share held by him as there are directors to be elected and for whose election the shareholder has a right to vote. Cumulative voting shall not be permitted in the election of directors or otherwise. Preemptive rights to purchase additional shares of stock are denied.
3. Authorized Shares of Preferred Stock . The corporation shall have the authority to issue 5,000,000 shares of $.001 par value Preferred Stock, which may be issued in one or more series at the discretion of the board of directors. In establishing a series, the board of directors shall give to it a distinctive designation so as to distinguish it from the shares of all other series and classes, shall fix the number of shares in such series, and the preferences, rights and restrictions thereof. All shares of any one series shall be alike in every particular except as otherwise provided by these Articles of Incorporation or the Nevada Revised Statutes.”
3. The foregoing amendment of articles of incorporation has been duly approved by the board of directors.
4. The foregoing amendments of articles of incorporation have been duly approved by the required vote of shareholders in accordance with the Nevada Revised Statutes. The total number of outstanding common stock of the corporation is 99,108,000 and the total number of outstanding Series A Convertible Preferred Stock is -0-. The number of shares of common stock entitled to vote in favor of the amendment equaled or exceeded the vote required. The percentage vote required was more than 50%.
We further declare under penalty of perjury under the laws of the State of Nevada that the matters set forth in this certificate are true and correct of our own knowledge.
Date: May __, 2019
/s/ Lianyue Song
Lianyue Song, President